Vilon research in Canada investigates the immune-regulatory and epigenetic properties of this dipeptide bioregulator from the thymic family. Vilon (Lys-Glu) is a synthetic dipeptide analogue of the natural thymic bioregulator that was developed at the St. Petersburg Institute of Bioregulation and Gerontology. Canadian immunology and aging researchers study Vilon for its effects on T-lymphocyte differentiation, immune system restoration in aged models, and gene expression regulation through chromatin-level interactions.
T-Cell Regulation Research
Vilon is studied for its ability to regulate T-lymphocyte proliferation and differentiation in cell culture models. Canadian immunology researchers investigate how this short dipeptide influences T-cell subpopulation balance, cytokine production, and immune competence in models of immune dysfunction. Research suggests Vilon may modulate thymopoietin-like signalling pathways to restore T-cell maturation in aged or immunocompromised models.
Aging and Immune Restoration Research
Age-related immune decline (immunosenescence) is associated with thymic involution and reduced T-cell output. Canadian gerontology researchers study Vilon to understand whether short thymic dipeptides can restore elements of T-cell-mediated immunity in aged animal models, and through what epigenetic mechanisms this restoration occurs.
Sourcing Vilon in Canada
Research-grade Vilon is available in Canada from EhBuddy Peptides. Lab-tested for purity. For laboratory research use only.
Vilon represents the simplest tier of Khavinson peptide bioregulators, yet studies suggest significant immune regulatory activity from this minimal dipeptide structure in Canadian research models.
